The Importance of Locoregional Therapy in Metastatic Nasopharyngeal Cancer
JAMA Oncol
.
2020 Sep 1;6(9):1353-1354.
doi: 10.1001/jamaoncol.2020.1793.
Authors
Nadeem Riaz
1
,
Eric Sherman
2
,
Nancy Lee
1
3
Affiliations
1
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
2
Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
3
Department of Radiation Oncology, Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, New York.
PMID:
32701124
DOI:
10.1001/jamaoncol.2020.1793
No abstract available
Publication types
Comment
MeSH terms
Combined Modality Therapy
Humans
Nasopharyngeal Carcinoma / therapy
Nasopharyngeal Neoplasms* / therapy